Literature DB >> 6744289

Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors.

S W O'Connor, W F Bale.   

Abstract

We have measured the rate of influx (kin) of normal rat immunoglobulin G (IgG) from the blood into the fluid surrounding the cells of three syngeneic rat fibrosarcomas as well as rat skin, muscle, lung, and kidney. Also measured was the rate of efflux (kout) of IgG from the tumor and tissue back into the circulation. The value of kin ranged from 0.11 to 9.0% of the blood value (activity/ml blood) transferred/hr/g for the nonmalignant tissues and from 6.2 to 7.9% of the blood value transferred/hr/g for the three tumors. Dividing kin by the plasma volume of the tissue gave a measure of the permeability of the vascular bed of that tissue. This ratio was rather constant for the normal tissues studied; however, it was at least an order of magnitude larger in all three tumors, indicating that the vasculature of the tumors was very permeable to IgG. The interstitial fluid volume (IF) of the tumor and tissue was calculated. The IF of the three tumors contained approximately 0.5 ml of fluid per g, while the IF of normal tissues had values that ranged from 0.14 to 0.34 ml of fluid per g. Knowledge of the IF, kin, and kout allowed a calculation of the concentration of IgG in the fluid surrounding the cells of tumors and tissues. The concentration of IgG in the IF of the tumors was found to be 50% of the plasma concentration; this was larger than the concentration of IgG in the IF of normal tissues, where the values ranged from 9 to 28% of the plasma concentration. A model for Ab localization onto solid tumors was developed. The model was used to discuss the mechanism of localization as well as the physiological limits of drug- or isotope-coupled Ab localization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744289

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Accumulation of immunoglobulin G at focal sites of inflammation.

Authors:  M Juweid; H W Strauss; H Yaoita; R H Rubin; A J Fischman
Journal:  Eur J Nucl Med       Date:  1992

2.  Effect of isoelectric point on biodistribution and inflammation: imaging with indium-111-labelled IgG.

Authors:  C I ten Kate; A J Fischman; R H Rubin; A J Fucello; D Riexinger; R A Wilkinson; L Du; B A Khaw; H W Strauss
Journal:  Eur J Nucl Med       Date:  1990

3.  Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements.

Authors:  Thomas Schluep; Jungyeon Hwang; Isabel J Hildebrandt; Johannes Czernin; Chung Hang J Choi; Christopher A Alabi; Brendan C Mack; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

4.  Nitric oxide induced by tumor cells activates tumor cell adhesion to endothelial cells and permeability of the endothelium in vitro.

Authors:  K Yudoh; H Matsui; H Tsuji
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

5.  The interstitial distribution of macromolecules in rat tumours is influenced by the negatively charged matrix components.

Authors:  Helge Wiig; Christina C Gyenge; Olav Tenstad
Journal:  J Physiol       Date:  2005-06-30       Impact factor: 5.182

6.  Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats.

Authors:  Leslie A Khawli; Sirj Goswami; Ryan Hutchinson; Zephania W Kwong; Jihong Yang; Xiangdan Wang; Zhenling Yao; Alavattam Sreedhara; Tony Cano; Devin Tesar; Ihsan Nijem; David E Allison; Pin Yee Wong; Yung-Hsiang Kao; Cynthia Quan; Amita Joshi; Reed J Harris; Paul Motchnik
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

7.  Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo.

Authors:  P D Collins; D T Connolly; T J Williams
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Disposition characteristics of protein drugs in the perfused rat kidney.

Authors:  K Mihara; T Hojo; M Fujikawa; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

9.  Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma.

Authors:  L F Brown; L Van de Water; V S Harvey; H F Dvorak
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

10.  Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.

Authors:  Joshua I Park; Limin Cao; Virginia M Platt; Zhaohua Huang; Robert A Stull; Edward E Dy; Jeffrey J Sperinde; Jennifer S Yokoyama; Francis C Szoka
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.